SEC Form 4 · accession 0001209191-18-060817
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul M Silva
Officer — SVP & Corp Controller
Period of report
Dec 3, 2018
Accepted (ET)
Dec 4, 2018 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 3, 2018 | M | 809 | $86.52 | A | 16,896 | D | |
| Common Stock | Dec 3, 2018 | S | 809 | $186.52 | D | 16,087 | D | |
| Common Stock | holding | — | — | — | 169 | I | 401(K) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $86.52 | Dec 3, 2018 | M | 809 | A | — | Feb 2, 2027 | Common Stock | 809 | 7,281 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- F2The option vests in 16 quarterly installments from 02/03/2017.